Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

insulin detemir - Phase 3 | NOVO-B.CO Pipeline | CatalystAlert

Back to NOVO-B.CO

insulin detemir

Phase 3

Novo Nordisk A/S (NOVO-B.CO)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Diabetes

Clinical Trial

Last updated: 12/4/2025

Regulatory Approvals

EMA

5/31/2004

Levemir

Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Developer

NOVO-B.CO

Novo Nordisk A/S

Biotechnology•North America•NASDAQ